The CIMESTRA study: intra-articular glucocorticosteroids and synthetic DMARDs in a treat-to-target strategy in early rheumatoid arhtritis

Merete L Hetland; Kim Hørslev-Petersen

The CIMESTRA study: intra-articular glucocorticosteroids and synthetic DMARDs in a treat-to-target strategy in early rheumatoid arhtritis

Department of Clinical Medicine

Abstract

Treatment of early rheumatoid arthritis (RA) include aiming at disease control with early use of methotrexate (MTX) in monotherapy or in combination with glucocorticoids or other disease-modifying drugs (DMARDs). The CIMESTRA study applied an aggressive treatment with DMARD and intra-articular injections of glucocorticoids (i.a. GC) to control disease activity. This paper reviews the results of the five years' study.

Original language	English
Journal	Clinical and Experimental Rheumatology
Volume	30
Issue number	4 Suppl 73
Pages (from-to)	S44-9
ISSN	0392-856X
Publication status	Published - 2013

Access to Document

http://www.clinexprheumatol.org/article.asp?a=6491

Cite this

@article{61cd9f6c39814c2fae26cad3f71a85d2,

title = "The CIMESTRA study: intra-articular glucocorticosteroids and synthetic DMARDs in a treat-to-target strategy in early rheumatoid arhtritis",

abstract = "Treatment of early rheumatoid arthritis (RA) include aiming at disease control with early use of methotrexate (MTX) in monotherapy or in combination with glucocorticoids or other disease-modifying drugs (DMARDs). The CIMESTRA study applied an aggressive treatment with DMARD and intra-articular injections of glucocorticoids (i.a. GC) to control disease activity. This paper reviews the results of the five years' study.",

author = "Hetland, {Merete L} and Kim H{\o}rslev-Petersen",

year = "2013",

language = "English",

volume = "30",

pages = "S44--9",

journal = "Clinical and Experimental Rheumatology",

issn = "0392-856X",

publisher = "Pacini Editore SpA",

number = "4 Suppl 73",

}

TY - JOUR

T1 - The CIMESTRA study

T2 - intra-articular glucocorticosteroids and synthetic DMARDs in a treat-to-target strategy in early rheumatoid arhtritis

AU - Hetland, Merete L

AU - Hørslev-Petersen, Kim

PY - 2013

Y1 - 2013

N2 - Treatment of early rheumatoid arthritis (RA) include aiming at disease control with early use of methotrexate (MTX) in monotherapy or in combination with glucocorticoids or other disease-modifying drugs (DMARDs). The CIMESTRA study applied an aggressive treatment with DMARD and intra-articular injections of glucocorticoids (i.a. GC) to control disease activity. This paper reviews the results of the five years' study.

AB - Treatment of early rheumatoid arthritis (RA) include aiming at disease control with early use of methotrexate (MTX) in monotherapy or in combination with glucocorticoids or other disease-modifying drugs (DMARDs). The CIMESTRA study applied an aggressive treatment with DMARD and intra-articular injections of glucocorticoids (i.a. GC) to control disease activity. This paper reviews the results of the five years' study.

M3 - Journal article

SN - 0392-856X

VL - 30

SP - S44-9

JO - Clinical and Experimental Rheumatology

JF - Clinical and Experimental Rheumatology

IS - 4 Suppl 73

ER -

The CIMESTRA study: intra-articular glucocorticosteroids and synthetic DMARDs in a treat-to-target strategy in early rheumatoid arhtritis

Abstract

Access to Document

Fingerprint

Cite this